Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity.

Date publication

juin 2017

Journal

Radiation oncology (London, England)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BERNIER-CHASTAGNER Valérie , Pr PEIFFERT Didier

Tous les auteurs :
Jolnerovski M, Salleron J, Beckendorf V, Peiffert D, Baumann AS, Bernier V, Huger S, Marchesi V, Chira C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28622770

Résumé

To report grade ≥2 overall late rectal and urinary toxicities in patients (pts) with prostate cancer treated by intensity-modulated radiotherapy (IMRT) at 3 dose-levels. Identify predictors of radiation toxicity and report biochemical progression free survival (bPFS).

Mots clés

Intensity-modulated radiation therapy, Prognostic factors, Prostate cancer, Rectal and urinary toxicity

Référence

Radiat Oncol. 2017 Jun;12(1):99